Claudia Alia
Marco Terrigno
Irene Busti
Federico Cremisi
Matteo Caleo- 1CNR Neuroscience Institute, National Research Council (CNR), Pisa, Italy
- 2Laboratory of Biology, Scuola Normale Superiore, Pisa, Italy
- 3Department of Neuroscience, Psychology, Drugs and Child Health Area, School of Psychology, University of Florence, Florence, Italy
- 4Biophysics Institute (IBF), National Research Council (CNR), Pisa, Italy
- 5Department of Biomedical Sciences, University of Padua, Padua, Italy
- 6Padua Neuroscience Center, University of Padua, Padua, Italy
Brain injuries causing chronic sensory or motor deficit, such as stroke, are among the leading causes of disability worldwide, according to the World Health Organization; furthermore, they carry heavy social and economic burdens due to decreased quality of life and need of assistance. Given the limited effectiveness of rehabilitation, novel therapeutic strategies are required to enhance functional recovery. Since cell-based approaches have emerged as an intriguing and promising strategy to promote brain repair, many efforts have been made to study the functional integration of neurons derived from pluripotent stem cells (PSCs), or fetal neurons, after grafting into the damaged host tissue. PSCs hold great promises for their clinical applications, such as cellular replacement of damaged neural tissues with autologous neurons. They also offer the possibility to create in vitro models to assess the efficacy of drugs and therapies. Notwithstanding these potential applications, PSC-derived transplanted neurons have to match the precise sub-type, positional and functional identity of the lesioned neural tissue. Thus, the requirement of highly specific and efficient differentiation protocols of PSCs in neurons with appropriate neural identity constitutes the main challenge limiting the clinical use of stem cells in the near future. In this Review, we discuss the recent advances in the derivation of telencephalic (cortical and hippocampal) neurons from PSCs, assessing specificity and efficiency of the differentiation protocols, with particular emphasis on the genetic and molecular characterization of PSC-derived neurons. Second, we address the remaining challenges for cellular replacement therapies in cortical brain injuries, focusing on electrophysiological properties, functional integration and therapeutic effects of the transplanted neurons.
Introduction
Brain injuries represent a large variety of disabling pathologies. They may originate from different causes and affect distinct brain locations, leading to an enormous multiplicity of various symptoms ranging from cognitive deficits to sensorimotor disabilities. They can also result in secondary disturbances, such as epileptic foci, which occur within the lesioned and perilesional tissues (Herman, 2002). Indeed, frequently a secondary functional damage can take place in a region distant from the first insult (e.g., the hippocampus after traumatic brain injury), providing an explanation for cognitive and memory deficits arising after a brain lesion (Girgis et al., 2016). Brain injuries can have traumatic or non-traumatic etiologies, including focal brain lesions, anoxia, tumors, aneurysms, vascular malformations, encephalitis, meningitis and stroke (Teasell et al., 2007). In particular, stroke covers a vast majority of acquired brain lesions. Stroke is usually referred to as a sudden cerebrovascular dysfunction leading to focal deficits and/or impairment of global brain functions and lasting more than 24 h (Mackay and Mensah, 2004). Since brain function is strictly dependent on a constant supply of oxygen and glucose, normally assured by blood circulation, a sudden block of blood supply determines suppression of neural function in less than 1 min, primarily due to interference with synaptic functions (Hofmeijer and Van Putten, 2012). Brief blood deprivations may cause only a reversible damage, which becomes permanent only if the circulation is not promptly restored (Krnjević, 2008; Vrselja et al., 2019). The neocortex represents the highest level of cognitive and sensorimotor integration, and it is therefore not surprising that, independently of different etiologies, lesions occurring in the cerebral cortex are particularly impacting on the clinical phenotype (Delavaran et al., 2013). For example, an insult occurring in the motor cortex results in functional impairment of one or more body parts contralateral to the infarct. The degree of the motor impairment depends on many factors, such as the extent of the lesion, the identity of the damaged region and the effectiveness of the initial neuroprotective interventions.
Following stroke, there is a window of neuroplasticity during which the greatest gains in recovery occur (Zeiler and Krakauer, 2013). Indeed, in the first weeks after stroke a limited spontaneous restoration of function may be observed, and about 30% of stroke survivors are able to carry on everyday activities (Activity of Daily Living or ADLs, i.e., eating, drinking, walking, etc.) without any help (Mozaffarian et al., 2014). However, other patients do not recover at all (Winters et al., 2018). In particular, impairments of upper and lower limbs make very hard to retain a sufficient degree of independence in ADLs. These impairments can be ameliorated with a variable degree of success, through rehabilitation of the affected body parts, including several physical activities improving strength and coordination of the affected muscles and promoting recover of motility. Furthermore, combining rehabilitation with treatments that enhance neuroplasticity has been demonstrated to boost recovery (Alia et al., 2017; Spalletti et al., 2017) but further steps forward in the field are necessary for clinical translation.
Besides physical rehabilitation and plasticizing treatments, another therapeutic approach is cell-based therapy, which has been pioneered in the therapy of Parkinson Disease (PD). Indeed, initial studies showed that fetal dopaminergic neurons grafted in the striatum ameliorated PD symptoms, both in animal models (Herman and Abrous, 1994) and in patients (Lindvall et al., 1990; Kordower et al., 1998). Since fetal transplantation poises both ethical issues and technical challenges (Robertson, 2001), other non-neural cells, such as mesenchymal stem cells (MSCs), may represent a more accessible alternative. In fact, MSCs can be readily derived from various sources, show a low immunogenic effect and proved to be beneficial in stroke treatment (Eckert et al., 2013; Zhang and Chopp, 2013). Notably, MSCs-conditioned medium alone is sufficient for a similar therapeutic effect, suggesting that the beneficial effect is likely due to a bystander effect and trophic support, rather than actual cell replacement (Eckert et al., 2013). Recent clinical trials proved the safety of immortalized neural cells when stereotaxically injected in the brain of patients with stable paresis of the arm following an ischemic stroke (Kalladka et al., 2016). Finally, induced pluripotent stem cells (iPSCs) are easily accessible, since they can be reprogrammed starting from somatic cells, can be in vitro differentiated in the desired type of neurons and, being autologously derived and carry low risk of immune rejection (Jung et al., 2012; Trounson and DeWitt, 2016).
Due to the high clinical relevance of cerebral lesions, protocols to differentiate neural stem cells in telencephalic neurons are highly valuable. These protocols are frequently inspired by findings in neural development.
Developmentally Inspired Stem Cells Differentiation Paradigms
Attempts to generate identity-specific cortical neurons require exploitation of the right embryonic developmental signals in a culture dish. The six layers of the mammalian neocortex originate from inside-out in a timely regulated manner during embryonic development and are characterized by a specific pattern of gene expression and connectivity (reviewed in: Rubenstein, 2011; Bronner and Hatten, 2013; Greig et al., 2013; Lodato and Arlotta, 2015). Both intrinsic and environmental factors control the progressive restriction of competence of cortical progenitors resulting in the sequential generation of the different cortical neurons, with deeper layer cortical neurons generated earlier than upper layer neurons (Gorski et al., 2002; Kriegstein and Noctor, 2004; Molyneaux et al., 2007).
The hippocampus arises from the invagination of the dorsal midline of the telencephalon, adjacent to the cortical hem. The boundaries between choroid plexus, cortical hem and hippocampus are defined early in development by the non-overlapping expression of molecular markers signatures. In particular, BMP4/7 are strongly expressed by the choroid plexus (Grove et al., 1998; Bulchand et al., 2001), while the cortical hem expresses high level of WNT3a, WNT2, and WNT5, whose signaling is essential for the correct development of the hippocampus (Grove et al., 1998) (Figure 1A). Consistently, experiments in which the cortical hem is ablated, or hem-dependent WNT expression is abrogated or compromised, showed the crucial role of the cortical hem in the hippocampal development (Grove et al., 1998; Grove and Tole, 1999; Lee et al., 2000). The Dentate Gyrus (DG), the CA1 and CA3 layers are the different fields forming the hippocampal formation; each one has its own cellular composition, morphology, connectivity and expresses specific molecular markers. In particular, KA1, a glutamate receptor subunit, is detectable in the CA3, while SCIP, a POU-domain transcription factor, is expressed in the CA1. The pyramidal neurons of the CA1-3 originate in the more dorsal ventricular zone of the hippocampus and then migrate toward the pial surface on a glial scaffold (Nadarajah et al., 2001), while the DG cells arise from a smaller and specialized medial region close to the fimbria, the dentate neuroepithelium (Danglot et al., 2006). Furthermore, new neurons are generated in the hippocampus of rodents throughout life, while cortical neurogenesis rapidly subsides after birth (Eriksson et al., 1998; van Praag et al., 2002). This makes hippocampus the region of choice to assay the ability of in vitro produced PSC-derived hippocampal-like neural cells to make projections and to send them to appropriate targets.
Figure 1. (A) Drawing depicting the main morphogens involved in the patterning of the forebrain of a mouse embryo (E10). T, Telencephalon; D, Diencephalon. (B) Cartoon showing main signaling pathways active in differentiating PSC and the inhibitors most commonly used. BMP signaling: Noggin, Bone Morphogenetic Protein Receptor 1A Fc chimera (BMPR1A-Fc), LDN193189, or Dorsomorphin; WNT signaling: CHIR99021, Dickkopf-related protein 1 (Dkk1), IWR-1-endo, 53AH or WNT-C59; TGFβ signaling: Lefty, SB431542; SHH signaling: Cyclopamine. β: β-catenin (CTNNB1).
Pluripotent stem cells cultured in low-density, serum-free and feeder-free conditions, in absence of any exogenous growth factor, readily differentiate into neural progenitor cells (Tropepe et al., 2001; Ying et al., 2003). This process faithfully reproduces in vivo neurogenesis (reviewed in: van den Ameele et al., 2014; Brown et al., 2018; Varrault et al., 2019), following the same timely regulated sequential neurogenic waves observed in vivo (Eiraku et al., 2008; Gaspard et al., 2008; Bertacchi et al., 2013; Molyneaux et al., 2015), which is therefore conserved in vitro (Shen et al., 2006). In fact, differentiating PSCs give rise to neural rosettes expressing the early neural markers Sox1, Pax6 and Nestin and closely resembling the early embryonic neural tube (Perrier et al., 2004). When dissociated and replated, PSC-derived neural rosettes give rise to neural progenitor cells (NPCs) which subsequently differentiate into a heterogeneous mixture of different subtypes of neurons (GABAergic, dopaminergic, serotonergic, and cholinergic), astrocytes and oligodendrocytes (Zhang et al., 2001; Barberi et al., 2003). Furthermore, PSCs cultured in this conditions spontaneously acquire an anterior dorsal neural identity (Watanabe et al., 2005; Pankratz et al., 2007), while the addition of growth factors to the medium can steer the differentiation of PSCs toward midbrain/hindbrain (Kawasaki et al., 2000; Perrier et al., 2004) or spinal cord (Wichterle et al., 2002; Li et al., 2009) fates. Thus, PSCs are first committed toward an anterior neural fate and successively patterned by caudalizing factors to acquire a more posterior neural identity, supporting a mammalian model of default neural induction (Muñoz-Sanjuán and Brivanlou, 2002; Smukler et al., 2006; Stern, 2006; Levine and Brivanlou, 2007; Gaulden and Reiter, 2008). Finally, recent evidence suggest that the regionalization of the presumptive neural ectoderm precedes neural commitment; indeed these results further support the notion that FGF, WNT and RA signaling are required for the acquisition of posterior neural identity by PSCs differentiating in vitro (Metzis et al., 2018).
The positional identity of neural cells obtained by pluripotent cell during in vitro differentiation is often established by the simple study of their neurotransmitter phenotype (Eiraku and Sasai, 2011; Shi et al., 2012; Yu et al., 2014; Shiraishi et al., 2017), or by deeper investigation of their molecular nature through methods of global gene expression analysis (Bertacchi et al., 2013, 2014; Espuny-Camacho et al., 2013; Leemput et al., 2014; Edri et al., 2015; Yao et al., 2017; Terrigno et al., 2018a). However, specific neural subtypes present in different areas of the adult brain show, in addition to distinct gene expression profiles, also defined connectivity patterns, electrophysiological proprieties and morphologies (Cadwell et al., 2015; Fuzik et al., 2015; Tiklová et al., 2019). Whereas the molecular signature of neurons can be established prior their transplantation, the evaluation of all the other parameters require in vivo analysis. Understanding how to obtain a precise subtype of neuron, patterned with the proper temporal and positional identity, is pivotal and might have considerable repercussion on possible clinical applications.
In this review, we have considered available protocols to differentiate murine and human pluripotent stem cells into cortical- or hippocampal-like stem cells (Figures 2, 3) expressing at least a forebrain marker (FOXG1 or EMX1/2) and an early cortical or hippocampal marker (TBR1/2, BCL11B or PROX1).
Figure 2. Table showing original reports of differentiation protocols of murine PSCs in cortical and hippocampal neurons. For each entry we indicated (from left to right): reference, schematic layout of the protocol, neural markers, cell-type markers, electrophysiological proprieties, target of transplantation assay to assess integration, global gene expression analysis to identify cell positional identity. If the information was available, we indicated the time of emergence of main cortical cell types (TBR1, BCL11B, BRN2, SATB2, and CUX1). Due to the sheer number of studies on this topic, derivative reports of minor modifications to previously published protocols are not included in this table. SFEBq, serum-free culture of embryoid body-like aggregates; EB, embryoid body; ML, monolayer; LD, low-density; sPSA, spontaneous post-synaptic activity; ePSA, evoked post-synaptic activity.
Figure 3. Table showing original reports of differentiation protocols of human PSCs in cortical and hippocampal neurons. With same criteria as those indicated in Figure 2 SFEBq, serum-free culture of embryoid body-like aggregates; EB, embryoid body; ML, monolayer; scRNAseq, single cell RNA sequencing; eAP, evoked action potential; sPSA, spontaneous post-synaptic activity; ePSA, evoked post-synaptic activity.
Derivation of Cortical-Like Neurons From Pluripotent Stem Cells
The derivation of cortical-like neurons from PSCs was first reported a decade ago by the laboratories of Pierre Vanderhaeghen (Gaspard et al., 2008) and Yoshiki Sasai (Eiraku et al., 2008). Interestingly, Sasai’s protocol is also the first report on 3D cortical organoid from both murine and human PSCs obtained by inhibiting both the endogenous WNT and TGFβ signaling. On the contrary, in Vanderhaeghen’s protocol PSCs are cultured as low density adherent monolayer in a minimal, chemically defined medium supplied with a SHH inhibitor, Cyclopamine. Indeed, these authors pioneered the generation of cortical-like cells from PSCs, paving the road for the subsequent studies on human PSCs and induced PSCs (Figures 2, 3). Notably, cortical-like cultures, expressing anterior neural markers (FOXG1 and EMX1/2) and enriched in several cortical cell types (BCL11B, TBR1/2, SATB2, BRN2, and CUX1), can be obtained by simply differentiating PSCs, cultured in suspension as embryoid bodies (Ebs), or as attached monolayer, in a chemically defined minimum medium, devoid of any grow factors (Gaspard et al., 2008; Li et al., 2009; Zeng et al., 2010; Lancaster et al., 2013). However, most authors block endogenous posteriorizing or ventralizing factors (Figure 1) to promote the commitment toward an anterior dorsal fate and enrich the culture in cortical cell types (Eiraku et al., 2008; Gaspard et al., 2008; Mariani et al., 2012; Shi et al., 2012; Bertacchi et al., 2013, 2014; Espuny-Camacho et al., 2013, 2018; Kadoshima et al., 2013; Renner et al., 2013; Yu et al., 2014; Paşca et al., 2015; Sakaguchi et al., 2015; Motono, 2016; Gunhanlar et al., 2017; Sarkar et al., 2018; Terrigno et al., 2018a), including BMP inhibitors (Noggin, BMPR1A-Fc, LDN193189, or Dorsomorphin), WNT inhibitors (Dkk1, IWR-1-endo, 53AH, or WNTC59) and TGFβ inhibitors (Lefty, SB431542). In addition, the default fate of PSC-derived neural progenitors appears to be dorsal, thus fewer protocols include the inhibition of SHH signaling (Gaspard et al., 2008; Yu et al., 2014; Sarkar et al., 2018).
Interestingly, by default PSC-derived cortical neurons appear to acquire mainly limbic and occipital cortical identities (Gaspard et al., 2008; Bertacchi et al., 2013; Terrigno et al., 2018b). In fact, cortical-like cultures show high levels of posterior cortical markers, namely COUP-TF1 (Gaspard et al., 2008; Bertacchi et al., 2013; Terrigno et al., 2018b), an orphan nuclear receptor that is expressed in a high posterior-lateral to low anterior-medial expression gradient by both progenitors and cortical neurons, and is required to balance the antero-posterior patterning of the neocortex (Armentano et al., 2007; Liu et al., 2010). In addition, heterotopic transplantation experiments into the adult murine cortex showed patterns of projection strikingly similar to grafted embryonic visual cortical cells (Michelsen et al., 2015; Espuny-Camacho et al., 2018), supporting the hypothesis of a default occipital fate for PSC-derived neurons. Indeed, treatment with the morphogen FGF8 can induce frontal motor cortical fates in PSC-derived cultures (Eiraku et al., 2008; Kadoshima et al., 2013; Imaizumi et al., 2018; Terrigno et al., 2018b). Intriguingly, Motono et al. reported the generation of PSC-derived anterior cortical neurons (low COUP-TF1 / high SP8 expression) by blocking both the canonical and non-canonical WNT signaling with an inhibitor of Porcupine (PORCN), a membrane-bound O-acyltransferase involved in the palmitoylation, and subsequent secretion, of WNT proteins (Motono et al., 2016). Although these results remain to be confirmed by whole genome expression profiling of the cells and a more extensive analysis of their morphology and connectivity following homotopic and heterotopic transplantation, they are yet another example of how culture conditions profoundly influence the positional identity of PSC-derived cortical neurons. Finally, since different protocol to obtain cells with anterior cortical identity are now available (Eiraku et al., 2008; Kadoshima et al., 2013; Motono, 2016; Imaizumi et al., 2018; Terrigno et al., 2018b), further studies should focus on PSC-derived neurons with motor cortical identity transplanted in the damaged motor cortex.
Besides positional identity, the cellular composition of the cell culture has great clinical implications, since the projection pattern of transplanted PSC-derived neurons varies according to their cellular identity. That is, TBR1- and BCL11B-positive PSC-derived neurons transplanted in the adult brain generate, respectively, cortico-thalamic and corticofugal projections (Espuny-Camacho et al., 2013; Michelsen et al., 2015), consistently with the connectivity of normal TBR1- and BCL11B-positive cells. In fact, differentiating PSCs can generate all the cell-types of the six cortical layers (van den Ameele et al., 2014), although culture conditions strongly influence their ratio. Indeed, the production of cortical pyramidal neurons by PSCs cultured in minimal medium as monolayer cultures is strongly skewed toward lower layer identity (Gaspard et al., 2008; Espuny-Camacho et al., 2013). However, the proportion of upper cortical neurons can be increased by supplying retinoids during dual SMAD inhibition (Shi et al., 2012), by transplantation in host brain (Espuny-Camacho et al., 2013) or by culturing PSCs as aggregates (Eiraku et al., 2008; Mariani et al., 2012; Lancaster et al., 2013). Organoid cortical cultures more faithfully reproduce several features of in vivo corticogenesis (reviewed in Lancaster and Knoblich, 2014; Di Lullo and Kriegstein, 2017; Giandomenico and Lancaster, 2017), such as migration of newborn neurons on radial glia processes (Bamba et al., 2017), interkinetic nuclear migration (Paşca et al., 2015), and interactions and connections between different regions of the neuroepithelium, such as the interneuron migration and cortical invasion in 3D co-cultures of dorsalized and ventralized PSC-derived neurons (Birey et al., 2017). Finally, although these methods do not allow the identification of the signals responsible for PSC specification, aggregate cultures display higher axonal outgrowth (Chandrasekaran et al., 2017) and cell survival (Daviaud et al., 2018) following cortical transplantation, holding great promises for in vitro modeling of neurodegenerative diseases (Quadrato et al., 2016).
During telencephalic development, GABAergic interneurons are generated in the subpallial caudal and medial ganglionic eminence (CGE and MGE) and migrate tangentially to the cortex and hippocampus (Marín and Rubenstein, 2001; Xu et al., 2004; Hansen et al., 2013; Ma et al., 2013). Several neurological disorders are caused by dysfunctions of the GABAergic system and in the last decades GABAergic cell-based therapies have emerged as a promising treatment in restoring the lost balance between inhibitory and excitatory circuits (Danjo et al., 2011; reviewed in Alvarez Dolado and Broccoli, 2011; Hunt et al., 2013; Shetty and Upadhya, 2016). Furthermore, several groups were able to efficiently generate forebrain GABAergic interneurons from PSCs (Gaspard et al., 2008; Li et al., 2009; Zeng et al., 2010; Falk et al., 2012; Germain et al., 2013; Liu et al., 2013; Maroof et al., 2013; Nicholas et al., 2013; Tornero et al., 2013; Yuan et al., 2015; Liao et al., 2016; Sun et al., 2016; Xu et al., 2016). However, due to the ventral origin of the forebrain interneurons, PSCs committed in culture to dorsal telencephalic fates, such as cortex and hippocampus, generate mainly glutamatergic neurons (Zhang et al., 2001; Bibel et al., 2004; Eiraku et al., 2008; Gaspard et al., 2008, 2009; Bertacchi et al., 2013, 2014; Espuny-Camacho et al., 2013; Yu et al., 2014; Michelsen et al., 2015; Livesey et al., 2016; Motono, 2016; Sarkar et al., 2018; Terrigno et al., 2018a). Since GABA-ergic inhibition is essential for maintaining the balanced activity of cortical neural circuits and for the development of neural network activity (Ben-Ari et al., 2007), grafting of PSC-derived cortical or hippocampal cultures enriched with interneurons could have significant clinical repercussions and should be further investigated.
Derivation of Hippocampal-Like Neurons From Pluripotent Stem Cells
The first report of PSC-derived neural progenitors committed to a medial pallial identity was by Sasai and colleagues (Eiraku et al., 2008). Since then, several authors described methods to commit PSC to either choroid plexus or hippocampus (Figures 1, 2; Yu et al., 2014; Sakaguchi et al., 2015; Sarkar et al., 2018; Terrigno et al., 2018a). Most of these protocols share an initial phase of WNT, BMP and TGFβ inhibition, followed by activation of BMP and WNT signaling, by either suppling WNT3a or a small-molecule inhibitor of GSK3 (CHIR). In particular, Sakaguchi et al. showed that a short-term activation of WNT and BMP signaling in anteriorized neural progenitors specifies a hippocampal primordium-like tissue in vitro, expressing the hippocampal markers ZBTB20, KA1 and PROX1; while a prolonged treatment results in increased expression of LMX1A and TTR, markers of choroid plexus (Sakaguchi et al., 2015). Consistently, other authors showed that double inhibition of WNT and BMP endogenous signaling in differentiating PSC followed by timely activation of WNT signaling results in hippocampal specification (Yu et al., 2014; Sarkar et al., 2018; Terrigno et al., 2018a). In particular, the laboratory of Fred Gage showed that a prolonged treatment with WNT3a results in the commitment of PSC to DG fate, while a shorter treatment and with a lower concentration of WNT3a specifies CA3 identity (Yu et al., 2014; Sarkar et al., 2018). Notably, PSC-derived hippocampal-like neurons, but not cortical-like cells, transplanted into adult hippocampus were capable of long-term survival, contacted relevant targets of the hippocampal formation and formed functional synaptic contacts with the host network, further confirming the importance of the identity match between transplanted cells and surrounding environment (Terrigno et al., 2018a).
In Vivo Integration and Therapeutic Effect of Grafted Exogenous Neural Cells in the Brain
Once obtained the cell type(s) of interest, the next step is to evaluate if these cells can properly integrate in the host tissue, sending short and long projections to their natural targets and rebuilding damaged circuitry. Neurons suitable for transplantation must be able to integrate into the host context, produce the appropriate type of neurotransmitter and neurotransmitter receptors and develop synapses with functionally relevant targets and electrophysiological properties of mature neurons.
Anatomical Characterization of Grafted Neurons in the Host Circuits
Initial reports showed that the outgrowth from grafts of fetal neurons in adult host brain was limited and dependent on the site of injection (Gonzalez et al., 1988; Isacson et al., 1988; Fricker et al., 1999). The first consistent observation of long-distance axons and extensive innervation of the host brain by fetal transplants following experimental deletion of cortical projection neurons was reported by Hernit-Grant and Macklis (1996) and Fricker-Gates et al. (2002). However, in these studies the specificity of efferent projections from the grafted cells toward appropriate host target sites was not assessed. Subsequently, Gaillard et al., 2007 described the reconstruction of damaged cortical circuitry in adult mice and the formation of long-range projections targeting the appropriate host regions, notably the pyramidal tract and the spinal cord. 2 months after the transplantation of fetal cortical tissue in the damaged motor cortex, they observed outgoing projections toward most of the cortical and subcortical targets of the cortical motor neurons, comparable to those established by neurons of the contralesional motor cortex. Furthermore, they verified that most of the grafted neurons sent projections along motor pathways, by injecting the retrograde tracer cholera toxin in the brain regions where fibers were found (i.e., thalamus and dorsolateral caudate putamen). Interestingly, the fact that in the same study visual grafts were not competent to replace degenerating motor pathways suggests that transplanted cells retain positional identity and functional capability of the donor. Altogether, these initial reports showed that transplanted embryonic neurons are able to extend long-range projections to distant targets with great specificity, suggesting that guidance cues persist in the adult brain or are re-expressed after injury, although no electrophysiological and/or behavioral evidence was provided to corroborate the anatomical observations (Gaillard et al., 2007).
More recently, Falkner et al. (2016) performed in vivo 2-photon imaging of embryonic cortical neurons transplanted 7 days after ablation of layer II-III callosal projecting neurons in the monocular visual cortex, evaluating longitudinal structural maturation, morphology, dendrite elongation and spine refinement of grafted neurons. Notably, already at 3–4 days post-transplantation, grafted neurons extended branched neurites, with identifiable growth cone and boutons, followed by the formation of apical dendrites which reached complete development within 4 weeks post-transplantation (wpt). Spine and bouton density greatly increased up to 4 wpt and then reached a plateau, while turnover rates increased at 5 wpt and subsequently stabilized after 8 wpt. Interestingly, as soon as 5 wpt, grafted cells displayed appropriate identity of pyramidal neurons and projected to the natural targets of V1 neurons, including ipsilateral visual areas, retrosplenial and entorhinal cortices and the corpus callosum. Furthermore, grafted cells received topographically correct synaptic inputs from appropriate cortical and subcortical regions, as assessed by performing monosynaptic rabies virus tracing. Overall, the authors showed that fetal neurons integrate adequately into the adult cerebral cortex, mature over time and re-establish a normal pattern of projection according to their original positional identity.
As previously discussed, in the last decade several groups worked to overcome the ethical and technical challenges of using fetal tissue, developing protocols to differentiate both mouse and human embryonic stem cells into neurons with appropriate cellular identity and area specification (Figures 1, 2).
Among the first, Pierre Vanderhaeghen and collaborators showed that murine PSC-derived pyramidal neurons grafted into the frontal cortex of neonatal mice and analyzed after 1 month displayed specific patterns of axonal projections corresponding to visual and limbic occipital cortex, despite the frontal site of transplantation (Gaspard et al., 2008). Furthermore, cultures transplanted at later stages of differentiation were enriched in later-born, superficial layer cell types. A similar pattern of projections was found 2 months after transplantation of human PSC-derived cortical neurons in frontal cortex of mouse pups, although 6 months post-transplantation the selectivity of these cells to contact the appropriate targets seems to decrease, with axonal projections reaching a wider range of regions, including motor and somatosensory areas (Espuny-Camacho et al., 2013). Noteworthy, Ideguchi and colleagues found no intrinsic regional identity in their PSC-derived pyramidal neurons, showing instead projection patterns coherent with the site of transplantation (Ideguchi et al., 2010). Thus, there may be a variability (likely depending on the protocol used for the differentiation) in the ability of the transplanted cells to retain the identity acquired in vitro.
In subsequent studies by Vanderhaeghen and collaborators, murine and human PSC-derived neurons were transplanted in a model of visual cortex lesion in adult mice and the re-establishment of the damaged pathways was assessed from 4 to 90 days after grafting (Michelsen et al., 2015). Grafted cells successfully differentiated, mainly in glutamatergic neurons, and showed reciprocal long-range axonal projections with targets of the damaged cortex such as the ipsilateral and contralateral cortex (layers II/III/IV), striatum (V), thalamus (VI) and midbrain/hindbrain nuclei (layer V). This study further confirmed that transplanted neurons display layer-specific patterns of projection in accordance with their molecular identity and consistent with the pattern of projection of native neurons of the visual cortex. Interestingly, these results were only obtained following homotopic transplantation in visual and not in motor cortex, as also confirmed by transplantation of fetal visual and motor cortical neural precursors. Human PSC-derived neurons maintained positional identity after transplantation and displayed the same projection properties of corresponding mouse cells, but required a longer time of maturation (Espuny-Camacho et al., 2018). Taken together, these results suggest that the success of transplantation in adult cortex is highly dependent on a strict match between the areal identity of the lesioned cortex and the positional identity of transplanted cells (Gaspard et al., 2008; Espuny-Camacho et al., 2013, 2018; Michelsen et al., 2015).
Among the first reports of mouse PSC used as cell therapy in animal models of stroke, Bühnemann et al. (2006) found that PSC-derived neural precursors transplanted into an Endothelin-1 (ET-1)-induced corticostriatal ischemic lesion, or in the perilesional striatum in rats, survived for up to 12 weeks and differentiated into distinct neuronal subtypes without expressing a specific cortical area-specific identity. However, the size of the surviving graft decreased from 4 to 12 weeks, probably due to graft rejection despite cyclosporine treatment, while paucity of fibers and high neuron mortality rate did not allow a proper analysis of the projection pattern.
Tornero et al., 2013 transplanted human IPSCs-derived, cortically committed or non-committed neural precursors, in the perilesional somatosensory cortex of a rat stroke model obtained by middle cerebral artery occlusion (MCAO). After 2 months they found that non-fated neural precursors cells (NPCs) proliferate more than their cortical counterpart. Both cell types migrated toward the ischemic lesion, but cortically fated cells differentiated more efficiently into TBR1- and SATB2-positive cortical neurons with a pyramidal morphology (Tornero et al., 2013). The same authors reported that grafted iPSC-derived cortical NPCs received synaptic inputs from the same areas as endogenous neurons (e.g., perilesional and contralateral cortex, ipsilateral and contralateral claustrum, specific thalamic nuclei, globus pallidus, etc.) as shown by the injection of a modified rabies virus that labeled monosynaptic afferents to grafted neurons. Finally, 6 months post-transplantation, immunoelectron microscopy confirmed that grafted neurons exhibited the ultrastructural features of mature neurons and formed synaptic contacts with host axon terminals, showing all of the ultrastructural criteria for synapses (Tornero et al., 2017).
Our group recently developed a protocol to produce either hippocampal or isocortical neurons that were then co-transplanted in healthy and lesioned brain regions. The analysis of in vivo projection pattern revealed that the different molecular identity acquired in vitro profoundly affect the different ability of these cells to extend axonal projections. In fact, we found that, accordingly to their molecular identity, isocortical neural precursors were not able to project once transplanted in the dentate gyrus (DG) of the hippocampus, contrary to PSC-derived hippocampal cells that properly elongated fibers to CA3 following endogenous hippocampal pathways. Instead, when grafted in their proper healthy cortical region, isocortical neurons sent projections toward the motor cortex and other cortical and subcortical targets. Interestingly, consistently with previous findings (de la Rosa-Prieto et al., 2017), fiber quantification revealed that the presence of an ischemic cortical lesion had an impressive impact in increasing the number of projections from isocortical cells, possibly through the same cellular mechanisms that spontaneously trigger and enhance post-stroke endogenous neural regeneration (Lindvall and Kokaia, 2015). Following stroke, the cortical cells elongated far reaching process that successfully integrated in motor pathways channeling in corticospinal tract segments, as the internal capsule (Terrigno et al., 2018b). However, PSC-derived isocortical cells transplanted into either intact or photothrombotic motor cortex failed in sending projections to thalamic nuclei and midbrain, in keeping with previous observations (Michelsen et al., 2015). This finding suggests that they might simply have maintained a general isocortical identity and that a further motor specification step may be required to generate also thalamic and midbrain projections.
Due to the clinical relevance and incidence of cortico-striatal lesions in humans, transplantation studies using neural precursors to rebuild lost circuitry focus mostly on sensory and motor cortices and striatum. However, since 1995 Fred Gage’s laboratory explored the possibility of transplanting cells in the hippocampus, publishing evidence that hippocampal neural stem cells long expanded in vitro, can integrate in the dentate gyrus and differentiate into mature neurons (Gage et al., 1995, 1998). Subsequently, it has been shown that pyramidal neurons obtained in vitro, integrate in the hippocampus, spreading throughout the CA3 region and the hilus, and elongate long projections to the contralateral hippocampus (Englund et al., 2002).
Electrophysiological Properties of Grafted Neurons
Studying electrophysiological properties of grafted neurons is an unavoidable step to demonstrate the effective integration in the pre-existing circuitry and the formation of active synapses with the host tissue.
Different strategies can be adopted to study functional properties of grafted neurons, each one with its own limitations. Whole cell patch clamp in an ex vivo preparation permits the visualization of fluorescent grafted cells with the certainty to record from a single grafted neuron, allowing the experimenter to precisely study the input/output connectivity of the transplanted cells with surrounding neurons. However, with this ex vivo technique it is not possible to test the response of grafted neurons to more physiological environmental events, such as somatic or visual stimuli. On the other hand, during in vivo electrophysiological recordings it is challenging to unambiguously identify grafted cells within the cortex, posing uncertainty on the source of the recorded activity. However, appropriate strategies have been developed to overcome these limitations.
Several studies showed that neurons transplanted in the cortex differentiate and mature in functional neurons, which are characterized by appropriate electrophysiological properties of resting membrane potential, spontaneous and induced action potentials (APs) and spontaneous post-synaptic activity in voltage or current clamp configuration (Bühnemann et al., 2006; Daadi et al., 2009; Oki et al., 2012; Espuny-Camacho et al., 2013, 2018; Tornero et al., 2013; Michelsen et al., 2015). In one of the first reports, Bühnemann et al. (2006) studied the electrophysiological proprieties of murine neural progenitors transplanted in a stroke model. The authors showed appropriate voltage-gated sodium and potassium currents with reversal potential similar to control neurons and blocked them using specific drugs (TTX and TEA, respectively). In addition, they recorded APs and spontaneous excitatory post-synaptic currents in graft-derived cells indicating synaptic input. Moreover, spontaneous APs decreased their duration over time (3 to 6 weeks after transplantation) suggesting that maturation processes could take place in this window (Bühnemann et al., 2006).
Action potentials of murine and human grafted neurons, transplanted both in naïve and pathological conditions, have been recorded in spontaneous conditions or in voltage clamp configuration, using a depolarizing current (Daadi et al., 2009; Oki et al., 2012; Espuny-Camacho et al., 2013, 2018; Tornero et al., 2013; Michelsen et al., 2015). Interestingly, many of these studies reported both excitatory and inhibitory spontaneous post-synaptic activity of transplanted cells. This activity was totally blocked using AMPA, NMDA or GABA antagonists (CNQX, AP-V and Gabazine, respectively), indicating that transplanted cells successfully received inputs from resident neurons. Specific inputs from host neurons have been detected by electrically stimulating a cortical site far away from the transplant (e.g., the contralateral cortex) and visualizing post-synaptic activity (PSP or PSC) in some of the grafted cells, although action potentials were not reported, suggesting mature and functional host-to-neurons synapses but with a low density distribution (Oki et al., 2012; Espuny-Camacho et al., 2013, 2018; Tornero et al., 2013). In addition to electrical stimulation, optogenetic tools have been exploited to study afferent connectivity to grafted neurons. In fact, Tornero et al. (2013) reported host thalamic inputs to transplanted iPSC-derived cells that differentiated into pyramidal neurons and fast spiking interneurons. After light stimulation of the host neurons expressing Channelrhodopsin-2 in the ventral thalamic nuclei, EPSP and EPSC were detected in grafted neurons 3 months after transplantation in the ipsilesional somatosensory cortex (Tornero et al., 2017).
In another recent study, Wuttke et al. (2018) tested the callosal host inputs on grafted PSC-derived neurons, using a remarkably clean optogenetic approach. TdTomato-conjugated Channelrhodopsin-2 was in utero electroporated in correspondence to the layer II-III neuron production peak during corticogenesis (E14.5). At birth, they transplanted PSC-derived neurons in the contralateral homotopic region to the electroporaton site. Starting from P21, in acute slice, they patched grafted neurons (GFP+) surrounded by TdTomato fibers arising from contralateral callosal projecting neurons. In voltage-clamp configurations, grafted neurons showed spontaneous excitatory and inhibitory post-synaptic activity (EPSC and IPSC). After light stimulation of the contralateral ChR2-electroporeted neurons, authors found post-synaptic currents in grafted neurons, although no action potentials occurred (Wuttke et al., 2018). Notably, based on the latencies between the onsets of the light pulses and the light-evoked postsynaptic currents, the authors were able to distinguish between excitatory, monosynaptic transcallosal connections and polysynaptic, inhibitory inputs mediated by local interneurons. Finally, the authors assessed whether the grafted cells established functional contacts with the host neurons. Thus, after grafting ChR2-TdTomato cells in the neonatal cortex, they patched host neurons and optogenetically stimulated transplanted cells. They found that stimulation of grafted neurons induced EPSC in endogenous cells with a greater efficiency in ipsilateral compared to contralateral host neurons (Wuttke et al., 2018).
The main challenge of cell therapy in adult disease models is to obtain neurons behaving as the endogenous counterparts and properly responsive to environmental stimuli. In this regard, Pierre Vanderhaeghen and colleagues (Michelsen et al., 2015) tested the responsiveness to a visual stimulus of in vitro differentiated murine pyramidal visual cortex neurons, after their transplantation in the visual cortex of adult mice that was previously lesioned by ibotenic acid injection. The authors performed extracellular recordings in anesthetized animals 3–9 months after the transplant, placing the electrode in the center of the transplant and performing juxtacellular neurobiotin injection after the recordings. Grafted neurons showed spontaneous action potential firing with frequencies similar to control neurons. Then, they tested whether a physiological stimulus (1-s flash) was able to evoke spike activity in grafted neurons and found that half of recorded neurons increased their firing rate after flash presentation, with latencies and frequencies similar to naïve control neurons (Michelsen et al., 2015).
Falkner et al. (2016) reported functional maturation of murine grafted neurons in visual cortex after a selective degeneration of callosal projecting neurons in adult mice. The authors transplanted E14.5–E15.5 fetal cortical cells previously transduced with a calcium indicator. From 4 to 15 weeks post-transplantation they performed 2-photon imaging sessions, presenting gratings to the contralateral eye and reported a refinement over time of the orientation preference with sharp tuning properties in the later sessions (Falkner et al., 2016). These data are remarkable as the transplanted neurons appear to assume tuning properties indistinguishable from endogenous pyramidal cells.
Tornero et al. (2013) grafted human iPSCs-derived cortical neural precursor cells in the somatosensory cortex, 1 week after MCAO. Animals were subjected to extracellular recordings 3 months after transplantation, during tactile stimulation of different parts of the body. In these experiments the electrode was placed in the core of the transplant at least 70 μm far away from the border. Spike sorting allowed the identification of single unit responses. Authors reported an increased firing rate of some grafted neurons after stimulation of nose, forelimbs or hindlimbs, with latencies ranging from 9 to 32 ms. Moreover, spontaneous activity in some of the recorded neurons was inhibited by tactile stimulation but with a longer latency (46 to 85 ms) indicating a fine integration of these neurons in the cortical network, responding with an opposite directionality to stimuli from different parts of the body. In addition to single unit recordings, Local Field Potentials (LFPs) were also analyzed in this paper. Authors demonstrated that the evoked potential after nose stimulation was affected in untreated MCAO rats, showing a longer latency with respect to healthy animals. Grafting IPSC-derived cortical neurons rescued this deficit, shortening the latencies and making them similar to those of naïve rats (Tornero et al., 2017). Indeed, this is one of the few studies in which functional recovery after stroke was corroborated by electrophysiological evidences, suggesting that the therapeutic effect of the grafted neurons may be, at least in part, mediated by actual cellular replacement.
In animal models of epilepsy, several studies reported reduction of electrographic seizure activity mediated by neural transplantation (Hattiangady et al., 2008; Baraban et al., 2009; Maisano et al., 2012; Hunt et al., 2013; Southwell et al., 2014). In particular, it has been showed that grafting fetal interneurons, derived from human PSCs, in the hippocampus of a pilocarpine-induced temporal lobe epilepsy murine model, rescued the epileptic phenotype, with a very significant decrease in the number of seizures and amelioration of cognitive deficits and hyperactivity (Cunningham et al., 2014). 4 months post-transplantation, grafted interneurons were integrated in the hippocampus and showed spontaneous post-synaptic currents and regular membrane potential properties. In addition, efferent graft-to-host connections were tested using whole-cell patch clamp of endogenous neurons during optogenetic stimulation of Chr2-expressing cells. Post-synaptic activity induced by blue light stimulation in host neighboring neurons was totally abolished by the GABA antagonist bicuculline, thus demonstrating correct and mutual integration (Cunningham et al., 2014).
Overall, these results suggest that exogenous neurons can successfully integrate in a pre-existing neural network, developing mature synaptic contacts with resident neurons. In selected cases, transplanted neurons appear to contribute to rescue functional deficits. To determine the extent of integration within the host circuitry, it is now of paramount importance to assess how the grafted cells respond in awake animals during physiologically relevant behaviors. So far, only sensory stimuli have been used to drive grafted neurons. Thus, it would be of great interest to evaluate the responsiveness of transplanted cells during motor tasks. Hopefully, further research will shed light on these important questions.
Therapeutic Effectiveness of Cell Replacement Therapies
The final goal of cell-based therapies is to improve recovery from functional deficits. In this context, beneficial effects of grafted cells can be ascribed to two, not mutually exclusive, mechanisms: (i) grafted cells could enhance functional recovery by secreting trophic factors and molecules with a neuroprotective/neuroplastic effect (also known as bystander effect); (ii) transplanted neurons could properly rebuild damaged circuitry, reestablishing lost sensorimotor synaptic connections. Consistently, cell-based therapy efforts are either directed toward grafting cells to produce and release trophic factors on site, or toward obtaining neurons with a specific identity in order to promote actual cell-replacement. Indeed, the fact that in several reports grafted cells were not detected in transplanted animals, despite an apparent functional improvement, indicates that: (i) the beneficial effect of the grafting was not related to long-term cell integration in the host neuronal circuitry and was exerted in the initial phase before the cells degenerated and (ii) the effect might be due to secretion of beneficial molecules released from grafted cells, or from resident cells stimulated by the grafting, in early post-implantation phase (Ramos-Cabrer et al., 2010; Oki et al., 2012; Hermanto, 2017).
Vascular endothelial growth factor (VEGF) has been implicated in mediating cell-induced functional recovery (Lee et al., 2007). In fact, neurons derived from human neural stem cells and overexpressing VEGF improved animal performance in the rotarod and limb placement tests when transplanted in the perilesional tissue after a hemorrhagic lesion, with early effects (8 days post-transplantation). Cells overexpressing VEGF also increased microvessels proliferation and diminished apoptotic cell death (Lee et al., 2007). Subsequently, Horie et al. (2011) confirmed that VEGF was responsible for the therapeutic effect of grafted neurons. They transplanted neurospheres in the peri-ischaemic cortex and observed an amelioration in the vibrissa-evoked forelimb placing test. Intriguingly, the recovery was totally abolished when VEGF was sequestered by a specific monoclonal antibody. In addition, histological investigations also reported a better blood brain barrier integrity, increased neovascularization and reduced inflammation (Horie et al., 2011). Moreover, the same authors showed that VEGF-mediated beneficial effects positively modulate axonal transport of host neurons, and stimulated axonal sprouting and dendritic plasticity (Andres et al., 2011).
It is generally accepted that grafted neurons could improve recovery by modulating neural plasticity. Indeed, transplanted interneurons induce plasticity in the host brain as reported by Southwell and colleagues, who demonstrated that grafting inhibitory interneurons in the adult visual cortex could re-open the critical period for ocular dominance plasticity (Southwell et al., 2010). In line with these results, hippocampal neural stem cells co-transplanted with astrocytes and microvascular endothelial cells in the hippocampus improved memory deficit after experimental stroke (Cai et al., 2015). Moreover, motor improvements have been reported following grafting of human derived neural precursors in rats with stroke (Daadi et al., 2008; Tornero et al., 2013; Tatarishvili et al., 2014), and after combination of grafting and exposure to enriched environment (Hicks et al., 2009). Recent findings confirmed the synergistic effect of coupling transplantation of murine E14.5 cortical NPCs with physical exercise, resulting in an increased and targeted fiber extension and a better motor improvement after aspiration of motor cortex in rats (Shimogawa et al., 2019).
Conclusion
The final goal of neuroscientists working in cell therapy for brain diseases is to restore injured neural circuits, thus rescuing physiological impairments. Among the challenges faced by the clinical application of cell-based therapies is the choice of the cell source (fetal cells, embryonic PSCs or iPSCs). Indeed, both embryonic PSCs and fetal transplantations raise ethical issues, since fetuses are hardly a reliable and scalable source of material. Thus, iPSCs represent a good choice from a translational point of view, showing low immunogenicity and posing no ethical concerns. Human Leukocyte Antigen (HLA)-matched banking of iPSCs would reduce both the time and the cost associated with the derivation of clinically compliant induced pluripotent stem cell lines (reviewed in: Solomon et al., 2015) and several groups are making continuing efforts to improve the immune compatibility of PSCs, reducing the risk of immune rejection caused by HLA mismatching (Rong et al., 2014; Gornalusse et al., 2017; Xu et al., 2019). In addition, of great importance is the development of footprint-free reprogramming tools, to induce pluripotency while preserving the genetic stability of the reprogrammed cells and reducing the risk of tumorigenesis after transplantation, together with optimized protocols, allowing a more efficient cell replacement of the different damaged brain regions (reviewed in Martin, 2017). Finally, further preclinical studies should involve chemogenetic and optogenetic tools for stimulating activity of transplanted neurons and endogenous cells, during specific tasks in which these cells are involved. This would facilitate the strengthening of correct and effective synaptic contacts among grafted and naïve neurons, via mechanisms of Hebbian plasticity. Indeed, the establishment of new neuronal circuitry required for functional recovery after brain injuries likely depends on the same mechanisms of synaptic plasticity that drive experience-dependent refinement of connections during brain development.
Author Contributions
All authors revised, wrote, and discussed the manuscript.
Funding
CA was supported by a fellowship from the Accademia Nazionale dei Lincei. This work was supported by the H2020 EXCELLENT SCIENCE – European Research Council (ERC) under grant agreement ID no. 692943 (BrainBIT).
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
Alia, C., Spalletti, C., Lai, S., Panarese, A., Lamola, G., Bertolucci, F., et al. (2017). Neuroplastic changes following brain ischemia and their contribution to stroke recovery: novel approaches in neurorehabilitation. Front. Cell Neurosci. 11:76. doi: 10.3389/fncel.2017.00076
Alvarez Dolado, M., and Broccoli, V. (2011). GABAergic neuronal precursor grafting: implications in brain regeneration and plasticity. Neural Plast. 2011:384216. doi: 10.1155/2011/384216
Andres, R. H., Horie, N., Slikker, W., Keren-Gill, H., Zhan, K., Sun, G., et al. (2011). Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain. Brain 134, 1777–1789. doi: 10.1093/brain/awr094
Armentano, M., Chou, S. J., Srubek Tomassy, G., Leingärtner, A., O’Leary, D. D. M. M., and Studer, M. (2007). COUP-TFI regulates the balance of cortical patterning between frontal/motor and sensory areas. Nat. Neurosci. 10, 1277–1286. doi: 10.1038/nn1958
Bamba, Y., Kanemura, Y., Okano, H., and Yamasaki, M. (2017). Visualization of migration of human cortical neurons generated from induced pluripotent stem cells. J. Neurosci. Methods 289, 57–63. doi: 10.1016/j.jneumeth.2017.07.004
Baraban, S. C., Southwell, D. G., Estrada, R. C., Jones, D. L., Sebe, J. Y., Alfaro-Cervello, C., et al. (2009). Reduction of seizures by transplantation of cortical GABAergic interneuron precursors into Kv1.1 mutant mice. Proc. Natl. Acad. Sci. U.S.A. 106, 15472–15477. doi: 10.1073/pnas.0900141106
Barberi, T., Klivenyi, P., Calingasan, N. Y., Lee, H., Kawamata, H., Loonam, K., et al. (2003). Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nat. Biotechnol. 21, 1200–1207. doi: 10.1038/nbt870
Ben-Ari, Y., Gaiarsa, J.-L., Tyzio, R., and Khazipov, R. (2007). GABA: a pioneer transmitter that excites immature neurons and generates primitive oscillations. Physiol. Rev. 87, 1215–1284. doi: 10.1152/physrev.00017.2006
Bertacchi, M., Pandolfini, L., D’Onofrio, M., Brandi, R., and Cremisi, F. (2014). The double inhibition of endogenously produced BMP and Wnt factors synergistically triggers dorsal telencephalic differentiation of mouse ES cells. Dev. Neurobiol. 75, 66–79. doi: 10.1002/dneu.22209
Bertacchi, M., Pandolfini, L., Murenu, E., Viegi, A., Capsoni, S., Cellerino, A., et al. (2013). The positional identity of mouse ES cell-generated neurons is affected by BMP signaling. Cell Mol. Life. Sci. 70, 1095–1111. doi: 10.1007/s00018-012-1182-3
Bibel, M., Richter, J., Schrenk, K., Tucker, K. L., Staiger, V., Korte, M., et al. (2004). Differentiation of mouse embryonic stem cells into a defined neuronal lineage. Nat. Neurosci. 7, 1003–1009.
Birey, F., Andersen, J., Makinson, C. D., Islam, S., Wei, W., Huber, N., et al. (2017). Assembly of functionally integrated human forebrain spheroids. Nature 545:54. doi: 10.1038/nature22330
Bronner, M., and Hatten, M. E. (2013). “Neurogenesis and Migration,” in Fundamental Neuroscience, 4th Edn, eds L. R. Squire, D. Berg, F. Bloom, S. Lac, A. Ghosh and N. C. Spitzer (Waltham, MA: Elsevier), 339–361. doi: 10.1016/b978-0-12-385870-2.00015-9
Brown, J., Quadrato, G., and Arlotta, P. (2018). “Chapter four - studying the brain in a dish: 3d cell culture models of human brain development and disease,” in Human Embryonic Stem Cells in Development, ed. A. H. Brivanlou (Cambridge: Academic Press), 99–122. doi: 10.1016/bs.ctdb.2018.03.002
Bühnemann, C., Scholz, A., Bernreuther, C., Malik, C. Y., Braun, H., Schachner, M., et al. (2006). Neuronal differentiation of transplanted embryonic stem cell-derived precursors in stroke lesions of adult rats. Brain 129, 3238–3248. doi: 10.1093/brain/awl261
Bulchand, S., Grove, E. A., Porter, F. D., and Tole, S. (2001). LIM-homeodomain gene Lhx2 regulates the formation of the cortical hem. Mech. Dev. 100, 165–175. doi: 10.1016/s0925-4773(00)00515-3
Cadwell, C. R., Palasantza, A., Jiang, X., Berens, P., Deng, Q., Yilmaz, M., et al. (2015). Electrophysiological, transcriptomic and morphologic profiling of single neurons using Patch-seq. Nat. Biotechnol. 34:199. doi: 10.1038/nbt.3445
Cai, Q., Chen, Z., Song, P., Wu, L., Wang, L., Deng, G., et al. (2015). Co-transplantation of hippocampal neural stem cells and astrocytes and microvascular endothelial cells improve the memory in ischemic stroke rat. Int. J. Clin. Exp. Med. 8, 13109–13117.
Chandrasekaran, A., Avci, H. X., Ochalek, A., Rösingh, L. N., Molnár, K., László, L., et al. (2017). Comparison of 2D and 3D neural induction methods for the generation of neural progenitor cells from human induced pluripotent stem cells. Stem Cell Res. 25, 139–151. doi: 10.1016/j.scr.2017.10.010
Cunningham, M., Cho, J.-H., Leung, A., Savvidis, G., Ahn, S., Moon, M., et al. (2014). hPSC-derived maturing GABAergic interneurons ameliorate seizures and abnormal behavior in epileptic mice. Cell Stem Cell 15, 559–573. doi: 10.1016/j.stem.2014.10.006
Daadi, M. M., Li, Z., Arac, A., Grueter, B. A., Sofilos, M., Malenka, R. C., et al. (2009). Molecular and magnetic resonance imaging of human embryonic stem cell-derived neural stem cell grafts in ischemic rat brain. Mol. Ther. 17, 1282–1291. doi: 10.1038/mt.2009.104
Daadi, M. M., Maag, A.-L., and Steinberg, G. K. (2008). Adherent self-renewable human embryonic stem cell-derived neural stem cell line: functional engraftment in experimental stroke model Chan-Ling T, ed. PLoS One 3:e1644. doi: 10.1371/journal.pone.0001644
Danglot, L., Triller, A., and Marty, S. (2006). The development of hippocampal interneurons in rodents. Hippocampus 16, 1032–1060. doi: 10.1002/hipo.20225
Danjo, T., Eiraku, M., Muguruma, K., Watanabe, K., Kawada, M., Yanagawa, Y., et al. (2011). Subregional specification of embryonic stem cell-derived ventral telencephalic tissues by timed and combinatory treatment with extrinsic signals. J. Neurosci. 31, 1919–1933. doi: 10.1523/JNEUROSCI.5128-10.2011
Daviaud, N., Friedel, R. H., and Zou, H. (2018). Vascularization and engraftment of transplanted human cerebral organoids in mouse cortex. eNeuro 5, ENEURO.219–ENEURO.218. doi: 10.1523/ENEURO.0219-18.2018
de la Rosa-Prieto, C., Laterza, C., Gonzalez-Ramos, A., Wattananit, S., Ge, R., Lindvall, O., et al. (2017). Stroke alters behavior of human skin-derived neural progenitors after transplantation adjacent to neurogenic area in rat brain. Stem Cell Res. Ther. 8:59. doi: 10.1186/s13287-017-0513-6
Delavaran, H., Sjunnesson, H., Arvidsson, A., Lindvall, O., Norrving, B., van Westen, D., et al. (2013). Proximity of brain infarcts to regions of endogenous neurogenesis and involvement of striatum in ischaemic stroke. Eur. J. Neurol. 20, 473–479. doi: 10.1111/j.1468-1331.2012.03877.x
Di Lullo, E., and Kriegstein, A. R. (2017). The use of brain organoids to investigate neural development and disease. Nat. Rev. Neurosci. 18, 573–584. doi: 10.1038/nrn.2017.107
Eckert, M. A., Vu, Q., Xie, K., Yu, J., Liao, W., Cramer, S. C., et al. (2013). Evidence for high translational potential of mesenchymal stromal cell therapy to improve recovery from ischemic stroke. J. Cereb. Blood Flow Metab. 33, 1322–1334. doi: 10.1038/jcbfm.2013.91
Edri, R., Yaffe, Y., Ziller, M. J., Mutukula, N., Volkman, R., David, E., et al. (2015). Analysing human neural stem cell ontogeny by consecutive isolation of Notch active neural progenitors. Nat. Commun. 6:6500. doi: 10.1038/ncomms7500
Eiraku, M., and Sasai, Y. (2011). Mouse embryonic stem cell culture for generation of three-dimensional retinal and cortical tissues. Nat. Protoc. 7, 69–79. doi: 10.1038/nprot.2011.429
Eiraku, M., Watanabe, K., Matsuo-Takasaki, M., Kawada, M., Yonemura, S., Matsumura, M., et al. (2008). Self-organized formation of polarized cortical tissues from escs and its active manipulation by extrinsic signals. Cell Stem Cell 3, 519–532. doi: 10.1016/j.stem.2008.09.002
Englund, U., Bjorklund, A., Wictorin, K., Lindvall, O., and Kokaia, M. (2002). Grafted neural stem cells develop into functional pyramidal neurons and integrate into host cortical circuitry. Proc. Natl. Acad. Sci. U.S.A. 99, 17089–17094. doi: 10.1073/pnas.252589099
Eriksson, P. S., Perfilieva, E., Bjork-Eriksson, T., Alborn, A. M., Nordborg, C., Peterson, D. A., et al. (1998). Neurogenesis in the adult human hippocampus. Nat. Med. 4, 1313–1317.
Espuny-Camacho, I., Michelsen, K. A., Linaro, D., Bilheu, A., Acosta-Verdugo, S., Herpoel, A., et al. (2018). Human pluripotent stem-cell-derived cortical neurons integrate functionally into the lesioned adult murine visual cortex in an area-specific way. Cell Rep. 23, 2732–2743. doi: 10.1016/j.celrep.2018.04.094
Espuny-Camacho, I., Michelsen, K. A., Gall, D., Linaro, D., Hasche, A., Bonnefont, J., et al. (2013). Pyramidal neurons derived from human pluripotent stem cells integrate efficiently into mouse brain circuits in vivo. Neuron 77, 440–456. doi: 10.1016/j.neuron.2012.12.011
Falk, A., Koch, P., Kesavan, J., Takashima, Y., Ladewig, J., Alexander, M., et al. (2012). Capture of neuroepithelial-like stem cells from pluripotent stem cells provides a versatile system for in vitro production of human neurons. PLoS One 7:e29597. doi: 10.1371/journal.pone.0029597
Falkner, S., Grade, S., Dimou, L., Conzelmann, K.-K., Bonhoeffer, T., Götz, M., et al. (2016). Transplanted embryonic neurons integrate into adult neocortical circuits. Nature 539, 248–253. doi: 10.1038/nature20113
Fricker, R. A., Carpenter, M. K., Winkler, C., Greco, C., Gates, M. A., and Björklund, A. (1999). Site-specific migration and neuronal differentiation of human neural progenitor cells after transplantation in the adult rat brain. J. Neurosci. 19, 5990–6005. doi: 10.1523/jneurosci.19-14-05990.1999
Fricker-Gates, R. A., Shin, J. J., Tai, C. C., Catapano, L. A., and Macklis, J. D. (2002). Late-stage immature neocortical neurons reconstruct interhemispheric connections and form synaptic contacts with increased efficiency in adult mouse cortex undergoing targeted neurodegeneration. J. Neurosci. 22, 4045–4056. doi: 10.1523/jneurosci.22-10-04045.2002
Fuzik, J., Zeisel, A., Máté, Z., Calvigioni, D., Yanagawa, Y., Szabó, G., et al. (2015). Integration of electrophysiological recordings with single-cell RNA-seq data identifies neuronal subtypes. Nat. Biotechnol. 34:175. doi: 10.1038/nbt.3443
Gage, F. H., Coates, P. W., Palmer, T. D., Kuhn, H. G., Fisher, L. J., Suhonen, J. O., et al. (1995). Survival and differentiation of adult neuronal progenitor cells transplanted to the adult brain. Proc. Natl. Acad. Sci. U.S.A. 92, 11879–11883. doi: 10.1073/pnas.92.25.11879
Gage, F. H., Kempermann, G., Palmer, T. D., Peterson, D. A., and Ray, J. (1998). Multipotent progenitor cells in the adult dentate gyrus. J. Neurobiol. 36, 249–266. doi: 10.1002/(sici)1097-4695(199808)36:2<249::aid-neu11>3.0.co;2-9
Gaillard, A., Prestoz, L., Dumartin, B., Cantereau, A., Morel, F., Roger, M., et al. (2007). Reestablishment of damaged adult motor pathways by grafted embryonic cortical neurons. Nat. Neurosci. 10, 1294–1299. doi: 10.1038/nn1970
Gaspard, N., Bouschet, T., Herpoel, A., Naeije, G., van den Ameele, J., and Vanderhaeghen, P. (2009). Generation of cortical neurons from mouse embryonic stem cells. Nat. Protoc. 4, 1454–1463. doi: 10.1038/nprot.2009.157
Gaspard, N., Bouschet, T., Hourez, R., Dimidschstein, J., Naeije, G., van den Ameele, J., et al. (2008). An intrinsic mechanism of corticogenesis from embryonic stem cells. Nature 455, 351–357. doi: 10.1038/nature07287
Gaulden, J., and Reiter, J. F. (2008). Neur-ons and neur-offs: Regulators of neural induction in vertebrate embryos and embryonic stem cells. Hum. Mol. Genet. 17, R60–R66. doi: 10.1093/hmg/ddn119
Germain, N. D., Banda, E. C., Becker, S., Naegele, J. R., and Grabel, L. B. (2013). Derivation and isolation of NKX2.1-positive basal forebrain progenitors from human embryonic stem cells. Stem Cells Dev. 22, 1477–1489. doi: 10.1089/scd.2012.0264
Giandomenico, S. L., and Lancaster, M. A. (2017). Probing human brain evolution and development in organoids. Curr. Opin. Cell Biol. 44, 36–43. doi: 10.1016/j.ceb.2017.01.001
Girgis, F., Pace, J., Sweet, J., and Miller, J. P. (2016). Hippocampal neurophysiologic changes after mild traumatic brain injury and potential neuromodulation treatment approaches. Front. Syst. Neurosci. 10:8. doi: 10.3389/fnsys.2016.00008
Gonzalez, M. F., Sharp, F. R., and Loken, J. E. (1988). Fetal frontal cortex transplanted to injured motor/sensory cortex of adult rats: reciprocal connections with host thalamus demonstrated with WGA-HRP. Exp. Neurol. 99, 154–165. doi: 10.1016/0014-4886(88)90135-5
Gornalusse, G. G., Hirata, R. K., Funk, S. E., Riolobos, L., Lopes, V. S., Manske, G., et al. (2017). HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells. Nat. Biotechnol. 35, 765–772. doi: 10.1038/nbt.3860
Gorski, J. A., Talley, T., Qiu, M., Puelles, L., Rubenstein, J. L. R., and Jones, K. R. (2002). Cortical excitatory neurons and glia, but not GABAergic neurons, are produced in the Emx1-expressing lineage. J. Neurosci. 22, 6309–6314. doi: 10.1523/jneurosci.22-15-06309.2002
Greig, L. C., Woodworth, M. B., Galazo, M. J., Padmanabhan, H., and Macklis, J. D. (2013). Molecular logic of neocortical projection neuron specification, development and diversity. Nat. Rev. Neurosci. 14, 755–769. doi: 10.1038/nrn3586
Grove, E. A., and Tole, S. (1999). Patterning events and specification signals in the developing hippocampus. Cereb. Cortex 9, 551–561. doi: 10.1093/cercor/9.6.551
Grove, E. A., Tole, S., Limon, J., Yip, L., and Ragsdale, C. W. (1998). The hem of the embryonic cerebral cortex is defined by the expression of multiple Wnt genes and is compromised in Gli3-deficient mice. Development 125, 2315–2325.
Gunhanlar, N., Shpak, G., van der Kroeg, M., Gouty-Colomer, L. A., Munshi, S. T., Lendemeijer, B., et al. (2017). A simplified protocol for differentiation of electrophysiologically mature neuronal networks from human induced pluripotent stem cells. Mol. Psychiatry 23, 1336–1344. doi: 10.1038/mp.2017.56
Hansen, D. V., Lui, J. H., Flandin, P., Yoshikawa, K., Rubenstein, J. L., Alvarez-Buylla, A., et al. (2013). Non-epithelial stem cells and cortical interneuron production in the human ganglionic eminences. Nat. Neurosci. 16:1576. doi: 10.1038/nn.3541
Hattiangady, B., Rao, M. S., and Shetty, A. K. (2008). Grafting of striatal precursor cells into hippocampus shortly after status epilepticus restrains chronic temporal lobe epilepsy. Exp. Neurol. 212, 468–481. doi: 10.1016/j.expneurol.2008.04.040
Herman, J.-P., and Abrous, N. D. (1994). Dopaminergic neural grafts after fifteen years: results and perspectives. Prog. Neurobiol. 44, 1–35. doi: 10.1016/0301-0082(94)90055-8
Herman, S. T. (2002). Epilepsy after brain insult: targeting epileptogenesis. Neurology 59, S21–S26.
Hermanto, Y. (2017). Transplantation of feeder-free human induced pluripotent stem cell – derived cortical neuron progenitors in adult male Wistar rats with focal brain ischemia. J. Neurosci. Res. 96, 863–874. doi: 10.1002/jnr.24197
Hernit-Grant, C. S., and Macklis, J. D. (1996). Embryonic neurons transplanted to regions of targeted photolytic cell death in adult mouse somatosensory cortex re-form specific callosal projections. Exp. Neurol. 139, 131–142. doi: 10.1006/exnr.1996.0088
Hicks, A. U., Lappalainen, R. S., Narkilahti, S., Suuronen, R., Corbett, D., Sivenius, J., et al. (2009). Transplantation of human embryonic stem cell-derived neural precursor cells and enriched environment after cortical stroke in rats: cell survival and functional recovery. Eur. J. Neurosci. 29, 562–574. doi: 10.1111/j.1460-9568.2008.06599.x
Hofmeijer, J., and Van Putten, M. J. A. M. (2012). Ischemic cerebral damage: An appraisal of synaptic failure. Stroke 43, 607–615. doi: 10.1161/STROKEAHA.111.632943
Horie, N., Pereira, M. P., Niizuma, K., Sun, G., Keren-Gill, H., Encarnacion, A., et al. (2011). Transplanted stem cell-secreted vascular endothelial growth factor effects poststroke recovery. Inflam. Vasc. Repair. Stem Cells 29, 274–285. doi: 10.1002/stem.584
Hunt, R. F., Girskis, K. M., Rubenstein, J. L., Alvarez-Buylla, A., and Baraban, S. C. (2013). GABA progenitors grafted into the adult epileptic brain control seizures and abnormal behavior. Nat. Neurosci. 16:692. doi: 10.1038/nn.3392
Ideguchi, M., Palmer, T. D., Recht, L. D., and Weimann, J. M. (2010). Murine embryonic stem cell-derived pyramidal neurons integrate into the cerebral cortex and appropriately project axons to subcortical targets. J. Neurosci. 30, 894–904. doi: 10.1523/JNEUROSCI.4318-09.2010
Imaizumi, K., Fujimori, K., Ishii, S., Otomo, A., Hosoi, Y., Miyajima, H., et al. (2018). Rostrocaudal areal patterning of human PSC-derived cortical neurons by FGF8 signaling. eneuro 5, ENEURO.368–ENEURO.317. doi: 10.1523/ENEURO.0368-17.2018
Isacson, O., Wictorin, K., Fischer, W., Sofroniew, M. V., and Björklund, A. (1988). Fetal cortical cell suspension grafts to the excitotoxically lesioned neocortex: anatomical and neurochemical studies of trophic interactions. Prog. Brain Res. 78, 13–26. doi: 10.1016/s0079-6123(08)60261-7
Jung, Y., Bauer, G., and Nolta, J. A. (2012). Concise review: induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products. Stem Cells 30, 42–47. doi: 10.1002/stem.727
Kadoshima, T., Sakaguchi, H., Nakano, T., Soen, M., Ando, S., Eiraku, M., et al. (2013). Self-organization of axial polarity, inside-out layer pattern, and species-specific progenitor dynamics in human ES cell-derived neocortex. Proc. Natl. Acad. Sci. U.S.A. 110, 20284–20289. doi: 10.1073/pnas.1315710110
Kalladka, D., Sinden, J., Pollock, K., Haig, C., McLean, J., Smith, W., et al. (2016). Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study. Lancet 388, 787–796. doi: 10.1016/S0140-6736(16)30513-X
Kawasaki, H., Mizuseki, K., Nishikawa, S., Kaneko, S., Kuwana, Y., Nakanishi, S., et al. (2000). Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 28, 31–40. doi: 10.1016/s0896-6273(00)00083-0
Kordower, J. H., Freeman, T. B., Chen, E. Y., Mufson, E. J., Sanberg, P. R., Hauser, R. A., et al. (1998). Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson’s disease. Mov. Disord. 13, 383–393. doi: 10.1002/mds.870130303
Kriegstein, A. R., and Noctor, S. C. (2004). Patterns of neuronal migration in the embryonic cortex. Trends Neurosci. 27, 392–399. doi: 10.1016/j.tins.2004.05.001
Krnjević, K. (2008). Electrophysiology of cerebral ischemia. Neuropharmacology 55, 319–333. doi: 10.1016/j.neuropharm.2008.01.002
Lancaster, M. A., and Knoblich, J. A. (2014). Generation of cerebral organoids from human pluripotent stem cells. Nat. Protoc. 9, 2329–2340. doi: 10.1038/nprot.2014.158
Lancaster, M. A., Renner, M., Martin, C., Wenzel, D., Bicknell, S., Hurles, M. E., et al. (2013). Europe PMC funders group cerebral organoids model human brain development and microcephaly. Nature 501, 373–379.
Lee, H. J., Kim, K. S., Park, I. H., and Kim, S. U. (2007). Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model lohuizen M van, ed. PLoS One 2:e156. doi: 10.1371/journal.pone.0000156
Lee, S. M., Tole, S., Grove, E., and McMahon, A. P. (2000). A local Wnt-3a signal is required for development of the mammalian hippocampus. Development 127, 457–467.
Leemput, J., Van De Boles, N. C., Kiehl, T. R., Corneo, B., Lederman, P., Menon, V., et al. (2014). NeuroResource CORTECON?: a temporal transcriptome analysis of in vitro human cerebral cortex development from human embryonic stem cells. Neuron 83, 51–68. doi: 10.1016/j.neuron.2014.05.013
Levine, A. J., and Brivanlou, A. H. (2007). Proposal of a model of mammalian neural induction. Dev. Biol. 308, 247–256. doi: 10.1016/j.ydbio.2007.05.036
Li, X.-J., Zhang, X., Johnson, M. A., Wang, Z.-B., LaVaute, T., and Zhang, S.-C. (2009). Coordination of sonic hedgehog and Wnt signaling determines ventral and dorsal telencephalic neuron types from human embryonic stem cells. Development 136, 4055–4063. doi: 10.1242/dev.036624
Liao, M.-C., Muratore, C. R., Gierahn, T. M., Sullivan, S. E., Srikanth, P., De Jager, P. L., et al. (2016). Single-cell detection of secreted aβ and sappα from human ipsc-derived neurons and astrocytes. J. Neurosci. 36, 1730–1746. doi: 10.1523/JNEUROSCI.2735-15.2016
Lindvall, O., and Kokaia, Z. (2015). Neurogenesis following stroke affecting the adult brain. Cold Spring Harb. Perspect. Biol. 7:a019034. doi: 10.1101/cshperspect.a019034
Lindvall, O., Rehncrona, S., Brundin, P., Gustavii, B., Astedt, B., Widner, H., et al. (1990). Neural transplantation in Parkinson’s disease: the Swedish experience. Prog. Brain Res. 82, 729–734.
Liu, Q., Dwyer, N. D., and O’Leary, D. D. (2010). Differential expression of COUP-TFI, CHL1, and two novel genes in developing neocortex identified by differential display PCR. J. Neurosci. 20, 7682–7690. doi: 10.1523/jneurosci.20-20-07682.2000
Liu, Y., Weick, J. P., Liu, H., Krencik, R., Zhang, X., Ma, L., et al. (2013). Medial ganglionic eminence-like cells derived from human embryonic stem cells correct learning and memory deficits. Nat. Biotechnol. 31, 440–447. doi: 10.1038/nbt.2565
Livesey, M. R., Magnani, D., Hardingham, G. E., Chandran, S., and Wyllie, D. J. A. (2016). Functional properties of in vitro excitatory cortical neurons derived from human pluripotent stem cells. J. Physiol. 594, 6573–6582. doi: 10.1113/JP270660
Lodato, S., and Arlotta, P. (2015). Generating neuronal diversity in the mammalian cerebral cortex. Annu. Rev. Cell Dev. Biol. 31, 699–720. doi: 10.1146/annurev-cellbio-100814-125353
Ma, T., Wang, C., Wang, L., Zhou, X., Tian, M., Zhang, Q., et al. (2013). Subcortical origins of human and monkey neocortical interneurons. Nat. Neurosci. 16:1588. doi: 10.1038/nn.3536
Mackay, J., and Mensah, G. A. (2004). The atlas of heart disease and stroke. J. Hum. Hyper. 19:505. doi: 10.1038/sj.jhh.1001852
Maisano, X., Litvina, E., Tagliatela, S., Aaron, G. B., Grabel, L. B., and Naegele, J. R. (2012). Differentiation and functional incorporation of embryonic stem cell-derived GABAergic interneurons in the dentate gyrus of mice with temporal lobe epilepsy. J. Neurosci. 32, 46–61. doi: 10.1523/JNEUROSCI.2683-11.2012
Mariani, J., Simonini, M. V., Palejev, D., Tomasini, L., Coppola, G., Szekely, A. M., et al. (2012). Modeling human cortical development in vitro using induced pluripotent stem cells. Proc. Natl. Acad. Sci. U.S.A. 109, 12770–12775. doi: 10.1073/pnas.1202944109
Marín, O., and Rubenstein, J. L. R. (2001). A long, remarkable journey: Tangential migration in the telencephalon. Nat. Rev. Neurosci. 2, 780–790. doi: 10.1038/35097509
Maroof, A. M., Keros, S., Tyson, J. A., Ying, S. W., Ganat, Y. M., Merkle, F. T., et al. (2013). Directed differentiation and functional maturation of cortical interneurons from human embryonic stem cells. Cell Stem Cell 12, 559–572. doi: 10.1016/j.stem.2013.04.008
Martin, U. (2017). Therapeutic application of pluripotent stem cells: challenges and risks. Front. Med. 4:229. doi: 10.3389/fmed.2017.00229
Metzis, V., Steinhauser, S., Pakanavicius, E., Gouti, M., Stamataki, D., Ivanovitch, K., et al. (2018). Nervous system regionalization entails axial allocation before neural differentiation. Cell 175, 1105.e–1118.e. doi: 10.1016/j.cell.2018.09.040
Michelsen, K. A., Acosta-Verdugo, S., Benoit-Marand, M., Espuny-Camacho, I., Gaspard, N., Saha, B., et al. (2015). Area-specific reestablishment of damaged circuits in the adult cerebral cortex by cortical neurons derived from mouse embryonic stem cells. Neuron 85, 982–997. doi: 10.1016/j.neuron.2015.02.001
Molyneaux, B. J., Arlotta, P., Menezes, J. R. L., and Macklis, J. D. (2007). Neuronal subtype specification in the cerebral cortex. Nat. Rev. Neurosci. 8, 427–437. doi: 10.1038/nrn2151
Molyneaux, B. J., Goff, L. A., Brettler, A. C., Chen, H. H., Brown, J. R., Hrvatin, S., et al. (2015). DeCoN: Genome-wide analysis of invivo transcriptional dynamics during pyramidal neuron fate selection in neocortex. Neuron 85, 275–288. doi: 10.1016/j.neuron.2014.12.024
Motono, M. (2016). Tissue engineering and regenerative medicine wnt-c59, a small-molecule WNT inhibitor, efficiently neurons from human pluripotent stem cells. Stem Cell Transl. Med. 5, 552–560. doi: 10.5966/sctm.2015-0261
Motono, M., Ioroi, Y., Ogura, T., and Takahashi, J. (2016). Tissue engineering and regenerative medicine WNT-C59, a small-molecule WNT inhibitor, efficiently neurons from human pluripotent stem cells. Stem Cell Transl Med 5, 552–560. doi: 10.5966/sctm.2015-0261
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., et al. (2014) Heart disease and stroke statistics–2015 update: a report from the American Heart Association. Circulation 131:e29-322. doi: 10.1161/CIR.0000000000000152
Muñoz-Sanjuán, I., and Brivanlou, A. H. (2002). Neural induction, the default model and embryonic stem cells. Nat. Rev. Neurosci. 3, 271–280. doi: 10.1038/nrn786
Nadarajah, B., Brunstrom, J. E., Grutzendler, J., Wong, R. O. L., and Pearlman, A. L. (2001). Two modes of radial migration in early development of the cerebral cortex. Nat. Neurosci. 4, 143–150. doi: 10.1038/83967
Nicholas, C. R., Chen, J., Tang, Y., Southwell, D. G., Chalmers, N., Vogt, D., et al. (2013). Functional maturation of hPSC-derived forebrain interneurons requires an extended timeline and mimics human neural development. Cell Stem Cell 12, 573–586. doi: 10.1016/j.stem.2013.04.005
Oki, K., Tatarishvili, J., Wood, J., Koch, P., Wattananit, S., Mine, Y., et al. (2012). Human-induced pluripotent stem cells form functional neurons and improve recovery after grafting in stroke-damaged brain. Stem Cells 30, 1120–1133. doi: 10.1002/stem.1104
Pankratz, M. T., Li, X.-J., Lavaute, T. M., Lyons, E. A., Chen, X., and Zhang, S.-C. (2007). Directed neural differentiation of human embryonic stem cells via an obligated primitive anterior stage. Stem Cells 25, 1511–1520. doi: 10.1634/stemcells.2006-0707
Paşca, A. M., Sloan, S. A., Clarke, L. E., Tian, Y., Makinson, C. D., Huber, N., et al. (2015). Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture. Nat. Methods 12, 671–678. doi: 10.1038/nmeth.3415
Perrier, A. L., Tabar, V., Barberi, T., Rubio, M. E., Bruses, J., Topf, N., et al. (2004). Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A 101, 12543–12548. doi: 10.1073/pnas.0404700101
Quadrato, G., Brown, J., and Arlotta, P. (2016). The promises and challenges of human brain organoids as models of neuropsychiatric disease. Nat. Med. 22:1220. doi: 10.1038/nm.4214
Ramos-Cabrer, P., Justicia, C., Wiedermann, D., and Hoehn, M. (2010). Stem cell mediation of functional recovery after stroke in the Rat Kleinschnitz C, ed. PLoS One 5:e12779. doi: 10.1371/journal.pone.0012779
Renner, M., Knoblich, J. A., Wenzel, D., Lancaster, M. A., Hurles, M. E., Homfray, T., et al. (2013). Cerebral organoids model human brain development and microcephaly. Nature 501, 373–379. doi: 10.1038/nature12517
Robertson, J. A. (2001). Human embryonic stem cell research: ethical and legal issues. Nat. Rev. Genet. 2, 74–78. doi: 10.1038/35047594
Rong, Z., Wang, M., Hu, Z., Stradner, M., Zhu, S., Kong, H., et al. (2014). An effective approach to prevent immune rejection of human ESC-derived allografts. Cell Stem Cell 14, 121–130. doi: 10.1016/j.stem.2013.11.014
Rubenstein, J. L. R. (2011). Annual research review: development of the cerebral cortex: implications for neurodevelopmental disorders. J. Child Psychol. Psychiatry 52, 339–355. doi: 10.1111/j.1469-7610.2010.02307.x
Sakaguchi, H., Kadoshima, T., Soen, M., Narii, N., Ishida, Y., Ohgushi, M., et al. (2015). Generation of functional hippocampal neurons from self-organizing human embryonic stem cell-derived dorsomedial telencephalic tissue. Nat. Commun. 6:8896. doi: 10.1038/ncomms9896
Sarkar, A., Mei, A., Paquola, A. C. M., Stern, S., Bardy, C., Klug, J. R., et al. (2018). Efficient generation of CA3 neurons from human pluripotent stem cells enables modeling of hippocampal connectivity in vitro. Cell Stem Cell 22, 684.e–697.e. doi: 10.1016/j.stem.2018.04.009
Shen, Q., Wang, Y., Dimos, J. T., Fasano, C. A., Phoenix, T. N., Lemischka, I. R., et al. (2006). The timing of cortical neurogenesis is encoded within lineages of individual progenitor cells. Nat. Neurosci. 9, 743–751. doi: 10.1038/nn1694
Shetty, A. K., and Upadhya, D. (2016). GABA-ergic cell therapy for epilepsy: advances, limitations and challenges. Neurosci. Biobehav. Rev. 62, 35–47. doi: 10.1016/j.neubiorev.2015.12.014
Shi, Y., Kirwan, P., Smith, J., Robinson, H. P. C., and Livesey, F. J. (2012). Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses. Nat. Neurosci. 15, 477–486. doi: 10.1038/nn.3041
Shimogawa, T., Sakaguchi, H., Kikuchi, T., Tsuchimochi, R., Sano, N., Torikoshi, S., et al. (2019). Therapeutic effects of combined cell transplantation and locomotor training in rats with brain injury. Npj Regen. Med. 4:13. doi: 10.1523/JNEUROSCI.5359-13.2014
Shiraishi, A., Muguruma, K., and Sasai, Y. (2017). Generation of thalamic neurons from mouse embryonic stem cells. Development 144, 1211–1220. doi: 10.1242/dev.144071
Smukler, S. R., Runciman, S. B., Xu, S., and van der Kooy, D. (2006). Embryonic stem cells assume a primitive neural stem cell fate in the absence of extrinsic influences. J. Cell Biol. 172, 79–90. doi: 10.1083/jcb.200508085
Solomon, S., Pitossi, F., and Rao, M. S. (2015). Banking on iPSC- Is it Doable and is it Worthwhile. Stem Cell Rev. Rep. 11, 1–10. doi: 10.1007/s12015-014-9574-4
Southwell, D. G., Froemke, R. C., Alvarez-Buylla, A., Stryker, M. P., and Gandhi, S. P. (2010). Cortical plasticity induced by inhibitory neuron transplantation. Science 327, 1145–1148. doi: 10.1126/science.1183962
Southwell, D. G., Nicholas, C. R., Basbaum, A. I., Stryker, M. P., Kriegstein, A. R., Rubenstein, J. L., et al. (2014). Interneurons from embryonic development to cell-based therapy. Science 344:1240622. doi: 10.1126/science.1240622
Spalletti, C., Alia, C., Lai, S., Panarese, A., Conti, S., Micera, S., et al. (2017). Combining robotic training and inactivation of the healthy hemisphere restores pre-stroke motor patterns in mice. Elife 6:e28662. doi: 10.7554/eLife.28662
Stern, C. D. (2006). Neural induction: 10 years on since the “default model”. Curr. Opin. Cell Biol. 18, 692–697. doi: 10.1016/j.ceb.2006.09.002
Sun, A. X., Yuan, Q., Tan, S., Xiao, Y., Wang, D., Khoo, A. T. T., et al. (2016). Direct induction and functional maturation of forebrain gabaergic neurons from human pluripotent stem cells. Cell Rep. 16, 1929–1941. doi: 10.1016/j.celrep.2016.07.035
Tatarishvili, J., Oki, K., Monni, E., Koch, P., Memanishvili, T., Buga, A.-M., et al. (2014). Human induced pluripotent stem cells improve recovery in stroke-injured aged rats. Restor. Neurol. Neurosci. 32, 547–558. doi: 10.3233/RNN-140404
Teasell, R., Bayona, N., Marshall, S., Cullen, N., Bayley, M., Chundamala, J., et al. (2007). A systematic review of the rehabilitation of moderate to severe acquired brain injuries. Brain Inj. 21, 107–112.
Terrigno, M., Bertacchi, M., Pandolfini, L., Baumgart, M., Calvello, M., Cellerino, A., et al. (2018a). The microRNA miR-21 is a mediator of FGF8 action on cortical COUP-TFI translation. Stem Cell Rep. 11, 756–769. doi: 10.1016/j.stemcr.2018.08.002
Terrigno, M., Busti, I., Alia, C., Pietrasanta, M., Arisi, I., D’Onofrio, M., et al. (2018b). Neurons generated by mouse ESCs with hippocampal or cortical identity display distinct projection patterns when co-transplanted in the adult brain. Stem Cell Rep. 10, 1016–1029. doi: 10.1016/j.stemcr.2018.01.010
Tiklová, K., Björklund, ÅK., Lahti, L., Fiorenzano, A., Nolbrant, S., Gillberg, L., et al. (2019). Single-cell RNA sequencing reveals midbrain dopamine neuron diversity emerging during mouse brain development. Nat. Commun. 10:581. doi: 10.1038/s41467-019-08453-1
Tornero, D., Tsupykov, O., Granmo, M., Rodriguez, C., Grønning-Hansen, M., Thelin, J., et al. (2017). Synaptic inputs from stroke-injured brain to grafted human stem cell-derived neurons activated by sensory stimuli. Brain 140, 692–706. doi: 10.1093/brain/aww347
Tornero, D., Wattananit, S., Madsen, M. G., Koch, P., Wood, J., Tatarishvili, J., et al. (2013). Human induced pluripotent stem cell-derived cortical neurons integrate in stroke-injured cortex and improve functional recovery. Brain 136, 3561–3577. doi: 10.1093/brain/awt278
Tropepe, V., Hitoshi, S., Sirard, C., Mak, T. W., Rossant, J., and van der Kooy, D. (2001). Direct neural fate specification from embryonic stem cells: a primitive mammalian neural stem cell stage acquired through a default mechanism. Neuron 30, 65–78. doi: 10.1016/s0896-6273(01)00263-x
Trounson, A., and DeWitt, N. D. (2016). Pluripotent stem cells progressing to the clinic. Nat. Rev. Mol. Cell Biol. 17, 194–200. doi: 10.1038/nrm.2016.10
van den Ameele, J., Tiberi, L., Vanderhaeghen, P., and Espuny-Camacho, I. (2014). Thinking out of the dish: what to learn about cortical development using pluripotent stem cells. Trends Neurosci. 37, 334–342. doi: 10.1016/j.tins.2014.03.005
van Praag, H., Schinder, A. F., Christie, B. R., Toni, N., Palmer, T. D., and Gage, F. H. (2002). Functional neurogenesis in the adult hippocampus. Nature 415, 1030–1034.
Varrault, A., Journot, L., and Bouschet, T. (2019). Cerebral cortex generated from pluripotent stem cells to model corticogenesis and rebuild cortical circuits: in vitro veritas? Stem Cells Dev. 33:scd.2018.0233. doi: 10.1089/scd.2018.0233
Vrselja, Z., Daniele, S. G., Silbereis, J., Talpo, F., Morozov, Y. M., Sousa, A. M. M., et al. (2019). Restoration of brain circulation and cellular functions hours post-mortem. Nature 568, 336–343. doi: 10.1038/s41586-019-1099-1
Watanabe, K., Kamiya, D., Nishiyama, A., Katayama, T., Nozaki, S., Kawasaki, H., et al. (2005). Directed differentiation of telencephalic precursors from embryonic stem cells. Nat. Neurosci. 8, 288–296.
Wichterle, H., Lieberam, I., Porter, J. A., and Jessell, T. M. (2002). Directed differentiation of embryonic stem cells into motor neurons. Cell 110, 385–397.
Winters, C., Kwakkel, G., van Wegen, E. E. H., Nijland, R. H. M., Veerbeek, J. M., and Meskers, C. G. M. (2018). Moving stroke rehabilitation forward: the need to change research Harvey RL, ed. NeuroRehabilitation 43, 19–30. doi: 10.3233/nre-172393
Wuttke, T. V., Markopoulos, F., Padmanabhan, H., Wheeler, A. P., Murthy, V. N., and Macklis, J. D. (2018). Developmentally primed cortical neurons maintain fidelity of differentiation and establish appropriate functional connectivity after transplantation. Nat. Neurosci. 21, 517–529. doi: 10.1038/s41593-018-0098-0
Xu, H., Wang, B., Ono, M., Kagita, A., Fujii, K., Sasakawa, N., et al. (2019). Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility. Cell Stem Cell 24, 566.e–578.e. doi: 10.1016/j.stem.2019.02.005
Xu, J. C., Fan, J., Wang, X., Eacker, S. M., Kam, T. I., Chen, L., et al. (2016). Cultured networks of excitatory projection neurons and inhibitory interneurons for studying human cortical neurotoxicity. Sci. Transl. Med. 8:333ra48. doi: 10.1126/scitranslmed.aad0623
Xu, Q., Cobos, I., De La Cruz, E., Rubenstein, J. L., and Anderson, S. A. (2004). Origins of cortical interneuron subtypes. J. Neurosci. 24:2612. doi: 10.1523/jneurosci.5667-03.2004
Yao, Z., Mich, J. K., Ku, S., Menon, V., Krostag, A. R., Martinez, R. A., et al. (2017). A single-cell roadmap of lineage bifurcation in human esc models of embryonic brain development. Cell Stem Cell 20, 120–134. doi: 10.1016/j.stem.2016.09.011
Ying, Q.-L., Stavridis, M., Griffiths, D., Li, M., and Smith, A. (2003). Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nat. Biotechnol. 21, 183–186. doi: 10.1038/nbt780
Yu, D. X., Di Giorgio, F. P., Yao, J., Marchetto, M. C., Brennand, K., Wright, R., et al. (2014). Modeling hippocampal neurogenesis using human pluripotent stem cells. Stem Cell Rep. 2, 295–310. doi: 10.1016/j.stemcr.2014.01.009
Yuan, F., Fang, K. H., Cao, S. Y., Qu, Z. Y., Li, Q., Krencik, R., et al. (2015). Efficient generation of region-specific forebrain neurons from human pluripotent stem cells under highly defined condition. Sci. Rep. 5, 1–11. doi: 10.1038/srep18550
Zeiler, S. R., and Krakauer, J. W. (2013). The interaction between training and plasticity in the poststroke brain. Curr. Opin. Neurol. 26, 609–616. doi: 10.1097/WCO.0000000000000025
Zeng, H., Guo, M., Martins-Taylor, K., Wang, X., Zhang, Z., Park, J. W., et al. (2010). Specification of region-specific neurons including forebrain glutamatergic neurons from human induced pluripotent stem cells. PLoS One 5:e11853. doi: 10.1371/journal.pone.0011853
Zhang, J., and Chopp, M. (2013). Cell-based therapy for ischemic stroke. Expert Opin. Biol. Ther. 13, 1229–1240. doi: 10.1517/14712598.2013.804507
Keywords: pluripotent stem cells, stroke, cortex, hippocampus, brain injuries, brain repair, cell-based therapy, differentiation protocols
Citation: Alia C, Terrigno M, Busti I, Cremisi F and Caleo M (2019) Pluripotent Stem Cells for Brain Repair: Protocols and Preclinical Applications in Cortical and Hippocampal Pathologies. Front. Neurosci. 13:684. doi: 10.3389/fnins.2019.00684
Received: 15 May 2019; Accepted: 14 June 2019;
Published: 06 August 2019.
Edited by:
Johannes Boltze, University of Warwick, United KingdomReviewed by:
Tristan Bouschet, INSERM U1191 Institut de Génomique Fonctionnelle (IGF), FranceZaal Kokaia, Lund Stem Cell Center, Sweden
Daniel Tornero, University of Barcelona, Spain
Copyright © 2019 Alia, Terrigno, Busti, Cremisi and Caleo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Claudia Alia, alia@in.cnr.it
†These authors have contributed equally to this work as first authors